In 2015, the United States transitioned to the ICD-10-CM/PCS, a comprehensive updated coding system for medical reimbursement. This transition was part of a larger move toward value-based reimbursement in U.S. health care and required nearly 2 decades of planning. As an unfunded mandate from Congress, it created a substantial financial burden for many groups within the health sector. This article traces the ICD-10 transition using the concept of the corporate governance of health care, attending to the role the state plays in mediating intercapitalist maneuvers. The ICD-10 was not a simple top-down declaration originating in a neutral state. Rather, it was produced and modified through lobbying efforts on the part of various stakeholders who, along with their competitors, would be affected by the transition in differential ways. The health information technology industry, in particular, stood to gain the most from this transition, at the expense of other capitalist players. An examination of the intercapitalist maneuevers behind the ICD-10 transition demonstrates that even when corporate powers govern U.S. health care, the role of the state should not be written off as inconsequential but rather interrogated and analyzed in relation to the corporate interests with which it is entangled.
ManchikantiLHammerMBoswellMVKayeADHirschJA.A seamless navigation to ICD-10-CM for interventional pain physicians: is a rude awakening avoidable?Pain Physician. 2016;
19(1):E1–E14.
ManchikantiLFalcoFJEHelm IiSHirschJA.First, do no harm by adopting evidence-based policy initiatives: the overselling of ICD-10 by congress with high expectations. Pain Physician. 2015;
18(2):E107–E113.
6.
ButlerM.Life after ICD-10: how the healthcare world will change after ICD-10’s implementation. J AHIMA. 2015;
86(6):22–27.
7.
IriartCFrancoTMerhyEE.The creation of the health consumer: challenges on health sector regulation after managed care era.Glob Health. 2011;
7:2.
Sunder RajanK.Biocapital: The Constitution of Postgenomic Life.
Durham, NC:
Duke University Press; 2006.
10.
Sunder RajanK.Pharmocracy: Value, Politics, and Knowledge in Global Biomedicine.
Durham, NC:
Duke University Press; 2017.
11.
HarveyD.Marx, Capital and the Madness of Economic Reason.
New York, NY:
Oxford University Press; 2018.
12.
Jasso-AguilarRWaitzkinH.Multinational corporations, the state, and contemporary medicine.Health Sociol Rev. 2011;
20(3):245–257.
13.
BensonPKirschS.Capitalism and the politics of resignation.Curr Anthropol. 2010;
51(4):459–486.
14.
WaitzkinHHellanderI.The history and future of neoliberal health reform: Obamacare and its predecessors.Int J Health Serv Plan Adm Eval. 2016;
46(4):747–766.
15.
MarjouaYBozicKJ.Brief history of quality movement in US healthcare.Curr Rev Musculoskelet Med. 2012;
5(4):265–273.
MerrySE.The Seductions of Quantification: Measuring Human Rights, Gender Violence, and Sex Trafficking.
Chicago, IL:
The University of Chicago Press; 2016.
21.
PorterT. Medical quantification: science, regulation, and the state. In: Jorland G, Opinel A, Weisz G, eds. Body Counts: Medical Quantification in Historical and Sociological Perspective. Montreal, Canada: McGill-Queen’s University Press; 2005:394–401.
22.
WaitzkinH; Working Group for Health Beyond Capitalism. Health Care Under the Knife: Moving beyond Capitalism for Our Health.
New York, NY:
Monthly Review Press; 2018.
23.
EriksonS. Metrics and market logics of global health. In: Adams V, ed. Metrics: What Counts in Global Health. Durham, NC: Duke University Press; 2016:147–162.
24.
ManchikantiLKayeADSinghVBoswellMV.The tragedy of the implementation of ICD-10-CM as ICD-10: is the cart before the horse or is there a tragic paradox of misinformation and ignorance?Pain Physician. 2015;
18(4):E485–495.
ZennerP. ICD-10 Savings: Who Will Be the Winners? us.milliman.com/insight/health/pdfs/ICD-10-savings-Who-will-be-the-winners/. Published 2009. Accessed November 18, 2016.
28.
LiPumaE.The Social Life of Financial Derivatives: Markets, Risk, and Time.
Durham, NC:
Duke University Press; 2017.
WaitzkinH. Disobedience: doctor workers, unite! In:
Waitzkin H, ed. Health Care Under the Knife: Moving Beyond Capitalism for Our Health. New York, NY: Monthly Review Press; 2018:25–32.
34.
KaplanB.How should health data be used?Camb Q Healthc Ethics CQ Int J Healthc Ethics Comm. 2016;
25(2):312–329.
TannerA. How data brokers make money off your medical records [published online ahead of print February 1, 2016]. Sci Am. doi:10.1038/scientificamerican0216-26
HarveyD.Seventeen Contradictions and the End of Capitalism: David Harvey. First issued as an Oxford University Press paperback.
Oxford, England:
Oxford University Press; 2015.
46.
AndersonM. The deprofessionalization and emerging social-class position of health professionals. In: Waitzkin H, ed. Health Care Under the Knife: Moving Beyond Capitalism for Our Health. New York, NY: Monthly Review Press; 2018:33–42.
47.
SchiffGWinchS. The degradation of medical labor and the meaning of quality in health care. In: Waitzkin H, ed. Health Care Under the Knife: Moving Beyond Capitalism for Our Health. New York, NY: Monthly Review Press; 2018:43–56.
48.
HimmelsteinDWoolhandlerS. The political economy of health reform. In: Waitzkin H, ed. Health Care Under the Knife: Moving Beyond Capitalism for Our Health. New York, NY: Monthly Review Press; 2018:57–68.
